Getein Testosterone Fast Test Kit (Immunofluorescence Assay) tests are used to assist in the diagnosis of female polycystic ovary syndrome and male testosterone insufficiency.
Getein fPSA Fast Test Kit is used for dynamic monitoring of patients with malignant tumors to assist in judging the disease process or treatment effect.
Getein AFP Fast Test Kit is used as an aid in the diagnosis and management of patients with liver cancer or cancer of the ovaries or testicles, and also help to monitor the health of people with cirrhosis or hepatitis.
CA125 Fast Test Kit (lmmunofluorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 125 (CA125) in serum, plasma or whole blood samples.
Cancer Antigen 15-3 Fast Test Kit (lmmunofluorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 15-3 (CA15-3) in serum or plasma samples.
CA19-9 Fast Test Kit (lmmunofuorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 19-9 (CA19-9) in serum, plasma or whole blood.
Getein Testosterone Fast Test Kit (Immunofluorescence Assay) tests are used to assist in the diagnosis of female polycystic ovary syndrome and male testosterone insufficiency.
Getein fPSA Fast Test Kit is used for dynamic monitoring of patients with malignant tumors to assist in judging the disease process or treatment effect.
Getein AFP Fast Test Kit is used as an aid in the diagnosis and management of patients with liver cancer or cancer of the ovaries or testicles, and also help to monitor the health of people with cirrhosis or hepatitis.
CA125 Fast Test Kit (lmmunofluorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 125 (CA125) in serum, plasma or whole blood samples.
Cancer Antigen 15-3 Fast Test Kit (lmmunofluorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 15-3 (CA15-3) in serum or plasma samples.
CA19-9 Fast Test Kit (lmmunofuorescence Assay) is intended for in vitro quantitative determination of Cancer Antigen 19-9 (CA19-9) in serum, plasma or whole blood.
